Skip to main content
Have a personal or library account? Click to login
A Complex Interplay: Navigating the Crossroads of Tobacco Use, Cardiovascular Disease, and the COVID-19 Pandemic: A WHF Policy Brief Cover

A Complex Interplay: Navigating the Crossroads of Tobacco Use, Cardiovascular Disease, and the COVID-19 Pandemic: A WHF Policy Brief

Open Access
|Jul 2024

Figures & Tables

Figure 1

Direct and indirect interplays between tobacco use, cardiovascular disease, and COVID-19.

MEASURESOBJECTIVES
Document systematically the use of tobacco and nicotine products in medical records
  • To generate robust data for measuring the association and impact of tobacco on specific diseases.

Study the interplays between tobacco use, cardiovascular disease, and emerging SARS-CoV-2 variants
  • To inform the public, health authorities, and governments of potential additional risks.

  • To implement timely and responsive tobacco control policies that further protect the public, including smokers, from emerging variants of interest or concern.

Ensure availability, accessibility, and affordability of tobacco cessation services, including during health emergencies
  • To reduce the impact of tobacco on noncommunicable diseases (e.g., cardiovascular disease), communicable diseases (e.g., COVID-19), and potential future pandemics.

  • To support individuals seeking to quit tobacco, including during health emergencies.

Leverage digital health solutions to enhance tobacco cessation services
  • To improve and ensure availability, accessibility, and affordability of tobacco cessation services at all times.

MEASURESOBJECTIVES
Accelerate the implementation and expansion of tobacco control policies
  • To capitalise on the momentum and political will to enact tobacco control regulations.

  • To minimise the impact of tobacco on future pandemics.

Maintain tobacco control policies instituted during health emergencies
  • To sustain progress made to protect public health, even beyond health emergencies.

Prioritise health equity in national pandemic responses
  • To promote health equity for marginalised and/or vulnerable populations during health emergencies.

  • To promote healthy lifestyles in stressful situations, such as pandemics.

  • To address the social determinants of health in national emergency preparedness and response plans.

Implement Article 5.3 of the WHO FCTC*
General Obligations: Conflicts of Interests, recognising that there is an irreconcilable conflict between the tobacco industry’s interest and public health policy interest.
  • To prevent tobacco industry interference in national pandemic responses, including through so-called corporate social responsibility activities.

  • To protect tobacco control laws, including pandemic-specific policies, from vested and commercial interest of the tobacco industry.

Monitor and oversee the activities of the tobacco industry during health emergencies
  • To prevent the dissemination of unsubstantiated information that may lead to avoidable health complications and deaths.

  • To prevent the tobacco industry from undermining tobacco control during national pandemic responses.

Implement Article 6 of the WHO FCTC*
Price and Tax Measures to Reduce the Demand for Tobacco
  • To reduce affordability and thereby discourage the consumption of tobacco and nicotine products in the population.

  • To generate revenue for government to allocate towards pandemic recovery initiatives.

Implement Article 8 of the WHO FCTC*
Protection from Exposure to Tobacco Smoke
  • To protect the population from second-hand smoke.

  • To prevent the potential transmission of airborne infectious agents.

Implement Article 12 of the WHO FCTC*
Education, Communication, Training, and Public Awareness
  • To raise awareness on the interplays between tobacco, cardiovascular disease, and COVID-19 or other infectious pathogens.

  • To educate and protect the general population from misinformation.

Implement Article 14 of the WHO FCTC*
Demand Reduction Measures Concerning Tobacco Dependence and Cessation
  • To reduce the impact of tobacco on noncommunicable diseases (e.g., cardiovascular disease), communicable diseases (e.g., COVID-19), and potential future pandemics.

  • To support individuals seeking to quit tobacco, including during health emergencies.

[i] *Countries that are not signatories to the WHO Framework Convention on Tobacco Control are also able to enact the above measures.

DOI: https://doi.org/10.5334/gh.1334 | Journal eISSN: 2211-8179
Language: English
Submitted on: Feb 7, 2024
Accepted on: Jun 10, 2024
Published on: Jul 1, 2024
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2024 Regina Dalmau, Abdullah M. Alanazi, Monika Arora, Amitava Banerjee, Eduardo Bianco, Diann E. Gaalema, Fastone M. Goma, Koji Hasegawa, Maki Komiyama, Mónica Pérez Ríos, Jeffrey Willett, Yunshu Wang, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.